1. Wischmeyer PE, Johnson BR, Wilson JE, Dingmann C, Bachman HM, Roller E, Tran ZV, Henthorn TK. A survey of propofol abuse in academic anesthesia programs. Anesth Analg. 2007. 105:1066–1071.
2. Monroe T, Hamza H, Stocks G, Scimeca PD, Cowan R. The misuse and abuse of propofol. Subst Use Misuse. 2011. 46:1199–1205.
3. Wilson C, Canning P, Caravati EA. The abuse potential of propofol. Clin Toxicol (Phila). 2010. 48:165–170.
4. Stocks G. Abuse of propofol by anesthesia providers. The case for re-classification as a controlled substance. J Addict Nurs. 2011. 22:57–62.
5. Park JH, Kim HJ, Seo JS. Medicolegal review of deaths related to propofol administration: analysis of 36 autopsied cases. Korean J Leg Med. 2012. 36:56–62.
6. Lee S, Lee MS, Kim YA, Ahn WS, Lee HC. Propofol abuse of the medical personnel in operation room in Korea. Korean J Leg Med. 2010. 34:101–107.
9. Mundy A. Alert on M.D. abuse of Jackson drug. The Wall Street Journal. 2009. 08. 06. A1.
10. Kim DK. Propofol use for sedation or sedation for propofol use? J Anesth. 2012. 26:289–291.
11. Roussin A, Montastruc JL, Lapeyre-Mestre M. Pharmacological and clinical evidences on the potential for abuse and dependence of propofol: a review of the literature. Fundam Clin Pharmacol. 2007. 21:459–466.
12. Chao J, Nestler EJ. Molecular neurobiology of drug addiction. Annu Rev Med. 2004. 55:113–132.
13. Bell DM, McDonough JP, Ellison JS, Fitzhugh EC. Controlled drug misuse by certified registered nurse anesthetists. AANA J. 1999. 67:133–140.
14. Langley MS, Heel RC. Propofol. A review of its pharmacodynamic and pharmacokinetic properties and use as an intravenous anaethetic. Drugs. 1988. 35:334–372.